Headaches in the Different Phases of Relapsing-Remitting Multiple Sclerosis A Tendency for Stabbing Headaches During Relapses

被引:28
|
作者
Ergun, Ufuk [1 ]
Ozer, Goekhan [1 ]
Sekercan, Sine [2 ]
Artan, Elif [2 ]
Kudiaki, Cigdem [2 ]
Ucler, Serap [1 ]
Coskun, Ozlem [1 ]
Inan, Levent [1 ]
机构
[1] Ankara Educ & Res Hosp, Minist Hlth, Dept Neurol, Ankara, Turkey
[2] Mersin Univ, Dept Psychol, Mersin, Turkey
关键词
multiple sclerosis; headache; stabbing headache; interferon; BECK DEPRESSION INVENTORY;
D O I
10.1097/NRL.0b013e3181906fc9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Primary headaches are known to be associated with multiple sclerosis. We aimed to determine headaches using ICHD-II in different phases of relapsing-remitting multiple sclerosis, and the correlation between headaches and several features of the disease. Results: Migraine (41.2%) and tension-type headaches (20.6%) were the most common headaches in remission, and primary stabbing headache (PSH) (27.8%) was common in the relapsing phase. Although headaches seemed to occur independently of disease duration, extended disability status scale, beck depression inventory scores, and treatments, the total number of headaches was correlated with periventricular lesions (P = 0.03) and tension-type headaches were correlated with spinal lesions in remission (P = 0.02). Total number of headaches was correlated with brain stern lesions ill the relapsing phase (P = 0.05). Conclusion: The high frequency of PSHs in relapse was notable, and, to the best of our knowledge, PSH was not reported in relapsing-remitting multiple sclerosis before. Further studies with larger samples are recommended.
引用
收藏
页码:212 / 216
页数:5
相关论文
共 50 条
  • [21] Deterioration of cardiac repolarization is different during primary progressive and relapsing-remitting multiple sclerosis
    Mikkola, A.
    Ojanen, A.
    Hartikainen, J.
    Remes, A. M.
    Simula, S.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 197 - 197
  • [22] Correlates and trajectories of relapses in relapsing–remitting multiple sclerosis
    Carolyn A. Young
    David J. Rog
    Basil Sharrack
    Radu Tanasescu
    Seema Kalra
    Timothy Harrower
    Alan Tennant
    Roger J. Mills
    Neurological Sciences, 2024, 45 : 2181 - 2189
  • [23] Cladribine TabletsIn Relapsing-Remitting Multiple Sclerosis
    Victoria J. Muir
    Greg L. Plosker
    CNS Drugs, 2011, 25 : 239 - 249
  • [24] Metabolomic profiling in relapsing-remitting multiple sclerosis
    Patel, Y.
    Vingara, L.
    Li, Y.
    Yu, H. J.
    Wagshul, M.
    Pelczer, I.
    Christodoulou, C.
    Melville, P.
    Maletic-Savatic, M.
    Krupp, L.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S80 - S80
  • [25] Quality of life in relapsing-remitting multiple sclerosis
    Dayapoglu, Nuray
    Tan, Mehtap
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2011, 27 (01) : 133 - 137
  • [26] Immunomonitoring measures in relapsing-remitting multiple sclerosis
    Matsui, M
    Araya, S
    Wang, HY
    Matsushima, K
    Saida, T
    JOURNAL OF NEUROIMMUNOLOGY, 2004, 148 (1-2) : 192 - 199
  • [27] Intestinal Permeability in Relapsing-Remitting Multiple Sclerosis
    M. C. Buscarinu
    S. Romano
    R. Mechelli
    R. Pizzolato Umeton
    M. Ferraldeschi
    A. Fornasiero
    R. Reniè
    B. Cerasoli
    E. Morena
    C. Romano
    N. D. Loizzo
    R. Umeton
    M. Salvetti
    G. Ristori
    Neurotherapeutics, 2018, 15 : 68 - 74
  • [28] Oral fumarate for relapsing-remitting multiple sclerosis
    Sorensen, Per Soelberg
    Sellebjerg, Finn
    LANCET, 2008, 372 (9648): : 1447 - 1448
  • [29] Fatigue in multiple sclerosis relapsing-remitting form
    Mendes, MF
    Tilbery, CP
    Balsimelli, S
    Felipe, E
    Moreira, MA
    Barao-Cruz, AM
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2000, 58 (2B) : 471 - 475
  • [30] Ibudilast in relapsing-remitting multiple sclerosis A neuroprotectant?
    Barkhof, F.
    Hulst, H. E.
    Drulovic, J.
    Uitdehaag, B. M. J.
    Matsuda, K.
    Landin, R.
    NEUROLOGY, 2010, 74 (13) : 1033 - 1040